Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the role of everolimus in combination with local Transcatheter
Arterial Chemoembolization (TACE) procedure in patients with localized unresectable
Hepatocellular Carcinoma (HCC).